Reports for LAMIVUDINE

Active Ingredient

LAMIVUDINE

Shortage reports
Brand name Strength Dosage Status Date Created Last updated Reports
APO-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2018-01-03 2018-01-16 34878
APO-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2019-01-03 2019-01-23 71098
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 300MG 150MG TABLET Resolved 2017-03-10 2017-05-23 14
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 300MG 150MG TABLET Actual shortage 2018-12-05 2019-03-15 68700
APO-LAMIVUDINE 150MG TABLET Resolved 2017-03-11 2017-05-16 664
APO-LAMIVUDINE 300MG TABLET Resolved 2017-07-11 2017-08-31 15271
APO-LAMIVUDINE-ZIDOVUDINE 300MG 150MG TABLET Resolved 2017-12-06 2018-07-03 31907
AURO-ABACAVIR/LAMIVUDINE 600MG 300MG TABLET Resolved 2018-12-21 2019-03-13 70316
HEPTOVIR 5MG SOLUTION Resolved 2017-08-10 2017-09-13 18727
KIVEXA 600MG 300MG TABLET Resolved 2019-01-30 2019-03-15 74011

Showing 1 to 10 of 15

Discontinuation reports
Brand name Strength Dosage Status Date Created Last updated Reports
APO-LAMIVUDINE 150MG TABLET To be discontinued 2018-09-07 2018-09-07 60557
APO-LAMIVUDINE 300MG TABLET To be discontinued 2018-09-07 2018-09-07 60560
APO-LAMIVUDINE HBV 100MG TABLET To be discontinued 2018-09-07 2018-09-07 60563